Compassionate, Cash-Rich Pharmaceutical Companies Prepare for Rocky Road Ahead

SUGAR LAND--December 3, 2010--Researched by Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical Industry has observed major changes over the past year, with performance being affected by factors such as listless prescription trends and escalating generic competition. Big Pharma's novel products are not expected to generate the same level of profit as current products that are losing patent protection. With revenue growth becoming stagnant, companies have been resorting to cost-cutting, share repurchasing, cash conservation, and mergers and acquisitions to drive bottom-line growth.